What are the preparations of lignocaine (lidocaine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preparations of Lignocaine (Lidocaine)

Available Formulations and Concentrations

Lignocaine is available in multiple formulations ranging from 0.5% to 10% concentrations, delivered as solutions for injection, topical gels, sprays, and nebulized preparations, with specific formulations selected based on the anatomical site and clinical indication. 1, 2

Injectable Solutions

  • 0.5% solution (5 mg/mL): Available in 50 mL single-dose vials containing 250 mg total 2
  • 1% solution (10 mg/mL): Available in multiple formats including 2 mL ampules (20 mg), 20 mL vials (200 mg), and 50 mL vials (500 mg) 2
  • 2% solution (20 mg/mL): Available in 2 mL ampules (40 mg), 10 mL ampules (200 mg), 20 mL vials (400 mg), and 50 mL vials (1000 mg) 2
  • 10% solution: Available for intramuscular injection, producing similar blood levels to larger volumes of less concentrated preparations 3

Topical Preparations for Airway Procedures

  • 2% gel (w/v): Preferred for nasal anaesthesia as it is better accepted by patients and yields lower blood levels compared to spray formulations 1
  • 4% aerosol (w/v): Used for anterior nares anaesthesia 1
  • 10% aerosol spray: Used for oropharyngeal anaesthesia 1
  • 4% nebulised solution: 4 mL administered via mouthpiece for oropharynx and vocal cord anaesthesia 1
  • 2-4% solution: Used for "spray as you go" technique during bronchoscopy 1
  • 1-2% boluses: Sprayed via bronchoscope for carina and bronchial anaesthesia 1

Formulations with Epinephrine (Adrenaline)

  • 1% lignocaine with epinephrine 1:200,000: The agent of choice for skin surgery, allowing maximum dose of 40 mL 4
  • Epinephrine-containing solutions increase maximum allowable doses by delaying local anaesthetic clearance and reducing peak blood concentrations 4
  • Should be avoided at fingers, toes, and penis due to risk of vasoconstriction-induced ischemia 4

Packaging and Storage Considerations

Container Types

  • Single-dose ampules: Preservative-free, available in glass 2
  • Single-dose vials: Preservative-free, available in glass teartop format 2
  • Multiple-dose vials: Contain 0.1% methylparaben as preservative, available in plastic fliptop format 2

Storage and Sterilization

  • Store at 20-25°C (68-77°F) under controlled room temperature conditions 2
  • Solutions in ampules and glass vials may be autoclaved once only at 15 pounds pressure, 121°C (250°F) for 15 minutes 2
  • Do not autoclave products in plastic vials 2

pH and Buffering Modifications

  • Standard lignocaine solutions have pH 6.5 (range 5.0-7.0) 2
  • Buffering with 8.4% sodium bicarbonate in 1:10 dilution significantly reduces injection pain and accelerates onset of anaesthesia (mean onset 34.4 seconds vs 109.8 seconds unbuffered) 5, 6
  • Epinephrine-containing solutions require acidic sodium metabisulphite to prevent oxidation, increasing injection pain, which can be mitigated by buffering 4

Temperature Considerations

  • Warming lignocaine to 37°C (body temperature) significantly reduces injection pain compared to room temperature administration (median pain score 10.0 vs 19.5) 7

Common Pitfalls to Avoid

  • Avoid using epinephrine-containing solutions in end-arterial territories (digits, penis) where vasoconstriction can cause tissue necrosis 4
  • Do not autoclave plastic vial preparations as this damages the container 2
  • Be aware that epinephrine-containing solutions have drug interactions with tricyclic antidepressants and nonselective beta-blockers 4
  • Multiple-dose vials contain methylparaben preservative which may cause allergic reactions in susceptible patients 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.